Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multi-Center, Randomized Dose-Finding Trial of rPA-102 Vaccine in Healthy Adult Volunteers

NCT00100724 is registered in ClinicalTrials.gov with VaxGen as lead sponsor.

NCT NCT00100724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00100724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multi-Center, Randomized Dose-Finding Trial of rPA-102 Vaccine in Healthy Adult Volunteers
Lead sponsor
VaxGen
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
July 31, 2005
Enrollment
480
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

anthrax